Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Entasis Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    ENTASIS THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Entasis Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Boston BioHub 35 Gatehouse Drive Waltham, MA USA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.entasistx.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Entasis lands first antibiotic approval eight years after spinning out of AZ
    Entasis lands first antibiotic approval eight years after spinning out of AZ

    https://endpts.com/fda-approves-antibiotic-for-pneumonia-caused-by-hard-to-treat-bacteria/

    Amber Tong ENDPTS
    25 May 2023
    Share Share
    Adcomm unanimously recommends Entasis' bacterial pneumonia candidate for resistant infections
    Adcomm unanimously recommends Entasis' bacterial pneumonia candidate for resistant infections

    https://endpts.com/adcomm-unanimously-recommends-entasis-bacterial-pneumonia-candidate-for-resistant-infections/

    Paul Schloesser ENDPTS
    17 Apr 2023
    Share Share
    Adcomm unanimously recommends Entasis' bacterial pneumonia
    Adcomm unanimously recommends Entasis' bacterial pneumonia

    https://endpts.com/adcomm-unanimously-recommends-entasis-bacterial-pneumonia-candidate-for-resistant-infections/

    Paul Schloesser ENDPTS
    17 Apr 2023
    Share Share
    Entasis Presents Safety Data from Landmark PIII ATTACK Trial at IDWEEK 2022
    Entasis Presents Safety Data from Landmark PIII ATTACK Trial at IDWEEK 2022

    https://www.globenewswire.com/news-release/2022/10/19/2537378/0/en/Entasis-Therapeutics-a-Wholly-Owned-Subsidiary-of-Innoviva-Presents-Efficacy-and-Safety-Data-from-Landmark-Phase-3-ATTACK-Trial-at-IDWEEK-2022.html

    GLOBENEWSWIRE
    19 Oct 2022
    Share Share
    Entasis , a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR
    Entasis , a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR

    https://www.globenewswire.com/news-release/2022/10/12/2532897/0/en/Entasis-Therapeutics-a-Wholly-Owned-Subsidiary-of-Innoviva-Announces-Data-on-SUL-DUR-to-be-Presented-at-IDWeek-2022.html

    GLOBENEWSWIRE
    12 Oct 2022
    Share Share
    Innoviva Completes Acquisition of Entasis Therapeutics
    Innoviva Completes Acquisition of Entasis Therapeutics

    https://www.businesswire.com/news/home/20220711005444/en

    BUSINESSWIRE
    11 Jul 2022
    Share Share
    Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Tx
    Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Tx

    https://www.businesswire.com/news/home/20220708005251/en

    BUSINESSWIRE
    08 Jul 2022
    Share Share
    Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM
    Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM

    https://www.globenewswire.com/news-release/2022/06/09/2459626/0/en/Entasis-Therapeutics-Presents-Data-on-Sulbactam-Durlobactam-and-ETX0462-at-2022-ASM-Microbe-Annual-Conference.html

    GLOBENEWSWIRE
    09 Jun 2022
    Share Share
    Innoviva to acquire Entasis Therapeutics for $2.20/share
    Innoviva to acquire Entasis Therapeutics for $2.20/share

    https://seekingalpha.com/news/3841688-innoviva-to-acquire-entasis-therapeutics-for-220share

    P. Ghumatkar SEEKING ALPHA
    24 May 2022
    Share Share
    Entasis Therapeutics Announces Q1 2022 Financial Results
    Entasis Therapeutics Announces Q1 2022 Financial Results

    https://www.globenewswire.com/news-release/2022/04/27/2430102/0/en/Entasis-Therapeutics-Announces-First-Quarter-2022-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    27 Apr 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search